News | May 08, 2023
Wacker acquires Spain-based biotech firm ADL BioPharma
The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters
The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters
The news on a shift in its focus comes after the refinement of Bayer’s early innovation framework
The return profile of NCDs is linked to BBL share price subject to minimum IRR of 12%.
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
Dozee plans to further tap over 2,000 hospitals in more than 100 districts
SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies
A funding to expand operations and provide better patient care
Natural Capsules Limited's shareholding will be reduced to 89.99%
At commercial scale, Bluestem's patent pending technologies will reduce carbon emission by an estimated 75% or more and be cost-competitive with petroleum based chemicals
Subscribe To Our Newsletter & Stay Updated
